Back to Journals » OncoTargets and Therapy » Volume 14

Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated by in cis EGFR T790M-C797S in NSCLC: A Case Report

Total article views   HTML views PDF downloads Totals
5,956 Dovepress* 5,109+ 672 5,781
PubMed Central* 847 353 1,200
Totals 5,956 1,025 6,981
*Since 28 April 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 1 1 2

View citations on PubMed Central and Google Scholar